NFKB1 and cancer: This mechanism is validated in studies showing that eradication of the RING-box protein Rbx2 in the SCFβ−TrCP complex triggered IκBα stabilization and NF-κB pathway inhibition, leading to re-sensitization of cancer cells toward RT (88) (Figure 2).